多区域分析揭示恶性脑肿瘤基因组与免疫多样性
研究对30例恶性脑肿瘤的93个空间独立区域进行全外显子、RNA和T细胞受体测序,比较原发与继发性脑肿瘤的免疫基因组特征。结果显示胶质瘤在基因组和新生抗原层面呈现更大空间异质性,T细胞克隆分布也具空间限制性,提示多区域分析对靶向和免疫治疗设计的重要性。
要点
- 胶质瘤在基因组改变、新生抗原和T细胞克隆上空间异质性高于脑转移瘤。
- 部分胶质瘤存在高度扩增但空间局限的T细胞克隆型。
- 原发与继发性脑恶性肿瘤的免疫基因组特征存在差异。
核心结论
- 胶质瘤在基因组、新生抗原和T细胞克隆层面的瘤内空间异质性显著高于脑转移瘤。
研究设计与样本
- 对30例恶性脑肿瘤的93个空间独立区域进行全外显子、RNA和T细胞受体测序。
主要发现
- 原发与继发性脑恶性肿瘤之间存在差异,胶质瘤在基因组和新生抗原水平显示更多空间异质性。
- 部分胶质瘤具有高度扩增但空间局限的T细胞克隆型,空间多样性与T细胞克隆分布一致。
临床怎么用
- 研究结果提示对胶质瘤进行多区域分析对临床或转化研究具有重要意义。
- 该免疫基因组图谱可为颅内恶性肿瘤的靶向和免疫治疗设计提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite some success in secondary brain metastases, targeted or immune-based therapies have shown limited efficacy against primary brain malignancies such as glioblastoma (GBM). Although the intratumoral heterogeneity of GBM is implicated in treatment resistance, it remains unclear whether this diversity is observed within brain metastases and to what extent cancer cell-intrinsic heterogeneity sculpts the local immune microenvironment. Here, we profiled the immunogenomic state of 93 spatially distinct regions from 30 malignant brain tumors through whole-exome, RNA, and T-cell receptor sequencing. Our analyses identified differences between primary and secondary malignancies, with gliomas displaying more spatial heterogeneity at the genomic and neoantigen levels. In addition, this spatial diversity was recapitulated in the distribution of T-cell clones in which some gliomas harbored highly expanded but spatially restricted clonotypes. This study defines the immunogenomic landscape across a cohort of malignant brain tumors and contains implications for the design of targeted and immune-based therapies against intracranial malignancies. SIGNIFICANCE: This study describes the impact of spatial heterogeneity on genomic and immunologic characteristics of gliomas and brain metastases. The results suggest that gliomas harbor significantly greater intratumoral heterogeneity of genomic alterations, neoantigens, and T-cell clones than brain metastases, indicating the importance of multisector analysis for clinical or translational studies.This article is highlighted in the In This Issue feature, p. 1.
引用
- Schaettler MO, Richters MM, Wang AZ, et al. Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis. Cancer Discov. 2021. PMID: 34610950. doi:10.1158/2159-8290.CD-21-0291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。